Previous issue | Next issue | Archive

Volume 2 (5); 2012

Editorial

Molecular Imaging and Radiotherapy: Theranostics for Personalized Patient Management
Irina Velikyan
Theranostics 2012; 2(5): 424-426. doi:10.7150/thno.4428
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Research Paper

thnov02p0472g03.jpg

Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 Pentetreotide
Ebrahim S. Delpassand, Amin Samarghandi, Jennifer Sims Mourtada, Sara Zamanian, Gregory D. Espenan, Roozbeh Sharif, Shawn MacKenzie, Kambiz Kosari, Omar Barakat, Shagufta Naqvi, John E. Seng, Lowell Anthony
Theranostics 2012; 2(5): 472-480. doi:10.7150/thno.3739
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Review

thnov02p0427g03.jpg

How Does the Patient Benefit from Clinical PET?
Jens Sörensen
Theranostics 2012; 2(5): 427-436. doi:10.7150/thno.3794
[Abstract] [Full text] [PDF] [PubMed] [PMC]


thnov02p0437g01.jpg

THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience
Richard P. Baum, Harshad R. Kulkarni
Theranostics 2012; 2(5): 437-447. doi:10.7150/thno.3645
[Abstract] [Full text] [PDF] [PubMed] [PMC]


thnov02p0448g05.jpg

Molecular Imaging Radiotherapy: Theranostics for Personalized Patient Management of Neuroendocrine Tumors (NETs)
Kjell Öberg
Theranostics 2012; 2(5): 448-458. doi:10.7150/thno.3931
[Abstract] [Full text] [PDF] [PubMed] [PMC]


thnov02p0481g04.jpg

Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer
M. Fani, H. R. Maecke, S. M. Okarvi
Theranostics 2012; 2(5): 481-501. doi:10.7150/thno.4024
[Abstract] [Full text] [PDF] [PubMed] [PMC]


thnov02p0502g05.jpg

Imaging Key Biomarkers of Tumor Angiogenesis
Marina V. Backer, Joseph M. Backer
Theranostics 2012; 2(5): 502-515. doi:10.7150/thno.3623
[Abstract] [Full text] [PDF] [PubMed] [PMC]


thnov02p0516g02.jpg

Imaging of Adrenal Masses with Emphasis on Adrenocortical Tumors
Anders Sundin
Theranostics 2012; 2(5): 516-522. doi:10.7150/thno.3613
[Abstract] [Full text] [PDF] [PubMed] [PMC]


toc.png

Pretargeted Molecular Imaging and Radioimmunotherapy
David M. Goldenberg, Chien-Hsing Chang, Edmund A. Rossi, William J. McBride, Robert M. Sharkey
Theranostics 2012; 2(5): 523-540. doi:10.7150/thno.3582
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Case Report

thnov02p0459g06.jpg

Lessons on Tumour Response: Imaging during Therapy with 177Lu-DOTA-octreotate. A Case Report on a Patient with a Large Volume of Poorly Differentiated Neuroendocrine Carcinoma
Ulrike Garske, Mattias Sandström, Silvia Johansson, Dan Granberg, Hans Lundqvist, Mark Lubberink, Anders Sundin, Barbro Eriksson
Theranostics 2012; 2(5): 459-471. doi:10.7150/thno.3594
[Abstract] [Full text] [PDF] [PubMed] [PMC]